AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea
· Delayed Price · Currency is KRW 17,560
-390 (-2.17%)
At close: Jul 11, 2025, 3:30 PM KST
AprilBio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| 29,686 | 27,514 | - | 200 | 23,396 | - | Upgrade
| |
Revenue Growth (YoY) | - | - | - | -99.15% | - | - | Upgrade
|
Cost of Revenue | 16.66 | 16.38 | 19.05 | 26.27 | 19.21 | 14.55 | Upgrade
|
Gross Profit | 29,669 | 27,498 | -19.05 | 173.73 | 23,377 | -14.55 | Upgrade
|
Selling, General & Admin | 6,723 | 6,654 | 4,582 | 4,054 | 4,490 | 1,995 | Upgrade
|
Research & Development | 2,902 | 3,205 | 8,038 | 6,925 | 13,892 | 6,781 | Upgrade
|
Other Operating Expenses | 67.95 | 63.2 | 74.54 | 75.96 | 61.16 | 35.47 | Upgrade
|
Operating Expenses | 10,390 | 10,629 | 13,369 | 11,648 | 18,930 | 9,173 | Upgrade
|
Operating Income | 19,279 | 16,869 | -13,388 | -11,474 | 4,446 | -9,188 | Upgrade
|
Interest Expense | -1,237 | -1,420 | -930.54 | -29.78 | -2,114 | -1,277 | Upgrade
|
Interest & Investment Income | 3,504 | 3,312 | 3,149 | 1,309 | 262.92 | 67.28 | Upgrade
|
Currency Exchange Gain (Loss) | 1,962 | 2,121 | 93.21 | 1,086 | -161.7 | - | Upgrade
|
Other Non Operating Income (Expenses) | -755.35 | -754.03 | -3,028 | 149.97 | -55,147 | 47.15 | Upgrade
|
EBT Excluding Unusual Items | 22,752 | 20,128 | -14,104 | -8,959 | -52,713 | -10,350 | Upgrade
|
Gain (Loss) on Sale of Assets | -0 | -0 | -25.87 | -0.01 | - | 5.64 | Upgrade
|
Other Unusual Items | -122.8 | -122.8 | - | - | - | - | Upgrade
|
Pretax Income | 22,629 | 20,005 | -14,130 | -8,959 | -52,713 | -10,344 | Upgrade
|
Income Tax Expense | - | - | - | - | - | -124.05 | Upgrade
|
Net Income | 22,629 | 20,005 | -14,130 | -8,959 | -52,713 | -10,220 | Upgrade
|
Net Income to Common | 22,629 | 20,005 | -14,130 | -8,959 | -52,713 | -10,220 | Upgrade
|
Shares Outstanding (Basic) | 22 | 22 | 21 | 20 | 8 | 3 | Upgrade
|
Shares Outstanding (Diluted) | 22 | 22 | 21 | 20 | 8 | 3 | Upgrade
|
Shares Change (YoY) | -8.17% | 2.66% | 9.11% | 134.61% | 139.04% | 400.04% | Upgrade
|
EPS (Basic) | 1022.72 | 913.04 | -662.00 | -458.00 | -6322.00 | -2930.00 | Upgrade
|
EPS (Diluted) | 1022.72 | 913.04 | -662.00 | -458.00 | -6322.00 | -2930.00 | Upgrade
|
Free Cash Flow | 22,366 | 21,514 | -10,571 | -6,794 | 2,546 | -7,774 | Upgrade
|
Free Cash Flow Per Share | 1010.83 | 981.92 | -495.25 | -347.29 | 305.34 | -2228.70 | Upgrade
|
Gross Margin | 99.94% | 99.94% | - | 86.87% | 99.92% | - | Upgrade
|
Operating Margin | 64.94% | 61.31% | - | -5737.15% | 19.00% | - | Upgrade
|
Profit Margin | 76.23% | 72.71% | - | -4479.64% | -225.31% | - | Upgrade
|
Free Cash Flow Margin | 75.34% | 78.19% | - | -3396.76% | 10.88% | - | Upgrade
|
EBITDA | 19,976 | 17,575 | -12,714 | -10,881 | 4,934 | -8,826 | Upgrade
|
EBITDA Margin | 67.29% | 63.88% | - | - | 21.09% | - | Upgrade
|
D&A For EBITDA | 696.23 | 706.33 | 674.42 | 593.44 | 487.25 | 361.36 | Upgrade
|
EBIT | 19,279 | 16,869 | -13,388 | -11,474 | 4,446 | -9,188 | Upgrade
|
EBIT Margin | 64.94% | 61.31% | - | - | 19.00% | - | Upgrade
|
Advertising Expenses | - | - | - | 14.33 | 3.5 | 8 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.